SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

After a strong earnings report, Intel's stock is trending, but not without volatility as the community debates whether government involvement and accounting practices are sustainable growth drivers. Some traders are targeting short positions, while others believe the pullback is a buying opportunity before a longer-term climb. Discussions also involve Intel's competition with TSMC and potential partnerships in the semiconductor sector.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending as discussions center around the company's potential in quantum computing and AI, especially following news of their quantum computing algorithm running on AMD chips. While some community members express skepticism and suggest alternative tech investments, others highlight IBM's leadership in quantum technology and potential for government partnerships. Overall, the stock's recent price action and analyst ratings are also contributing to the ongoing conversation.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around the revival of OG memes and a return to the "trenches" culture within the crypto space. Community members are expressing enthusiasm for its unique culture, built around the iconic Rage Guy meme, with many anticipating a potential "moonshot" event. The focus remains on community and the cultural movement rather than traditional chart analysis.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as traders discuss its potential for a short squeeze, pointing to high borrow costs and a tightly held float. Community members are actively debating the mechanics of a potential squeeze, with some suggesting insiders may be strategically accumulating shares. Bearish sentiment remains, with some traders adding to short positions, while bulls anticipate a significant price increase.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is trending due to a significant surge potentially fueled by news of insider buying and a milestone payment from Merck related to their Alzheimer's program. The community is actively discussing the low float and potential for a short squeeze, with some speculating about a potential run to double digits. However, some traders caution about potential dilution.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines is trending as community members discuss the potential impact of a Pentagon contract win and the involvement of Trump Jr. Some are also pointing to UMAC's existing investments in other drone companies, while others are speculating about the effect of a potential government shutdown on future contracts. The stock's price action, including a recent trading halt, has also fueled conversation.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc is trending as investors discuss its potential for a turnaround, spurred by the golden cross pattern and upcoming earnings. Community members are pointing to the large institutional ownership and catalysts such as government healthcare commitments and AI integration as reasons for potential upside. Some traders are also highlighting potential short squeeze opportunities.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

DECK is seeing active discussion around its recent performance and future prospects, with community members debating whether it's undervalued or facing headwinds. The stock's movement is attributed to factors beyond earnings, including concerns about guidance and potential tariff impacts. Bulls are pointing to the company's strong cash flow and potential buybacks.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending as investors discuss its potential as an AI infrastructure play, particularly following a reported partnership with Palantir. Community talking points include the company's fiber optic network and data center connectivity, with some seeing a possible short squeeze. Despite positive sentiment, concerns persist around debt and revenue growth.

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.

Genenta Science SpA - ADR

GNTA is trending due to a recently announced strategic partnership, leading to a significant pre-market surge. The community is discussing the potential for a short squeeze and the sustainability of the stock's gains, while also noting the company's focus on cancer therapies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Qualigen announced a $30 million partnership with BitGo to manage its C10 digital asset treasury, marking a deeper push into crypto and Web3 under Faraday Future’s ownership.</li><li>The company plans to diversify holdings across the top 10 cryptocurrencies through BitGo’s custody and OTC trading platform.</li><li>Retail sentiment on Stocktwits was ‘extremely bullish’ after the news, though some traders warned of profit-taking and a possible Friday pullback.</li></ul>Shares of Qualigen Therapeutics Inc. surged 62% in after-hours trading on Thursday after the company announced a partnership with BitGo to manage its C10 digital asset treasury, marking a major step in its shift toward crypto and Web3.The deal will see Qualigen allocate $30 million to a market-cap-weighted basket of the world’s top 10 cryptocurrencies (excluding stablecoins), using BitGo’s custody, liquidity, and OTC trading platform. The partnership is designed to bolster the company’s balance sheet diversification strategy while maintaining security through regulated cold storage and compliance-grade infrastructure.BitGo CEO Mike Belshe called the partnership “a $30 million multi-asset allocation that demonstrates the growing confidence among enterprises in building a digital-first treasury strategy.”&nbsp;<h2 class="st-heading-2">The Crypto Pivot&nbsp;</h2>The move follows Faraday Future Intelligent Electric’s announcement last month that it would&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-qualigen-therapeutics-stock-surging-nearly-300-premarket/chDQ1SyR3cV">invest $41 million in Qualigen</a>, giving the California-based EV maker a majority stake. Faraday contributed $30 million for roughly 55% ownership, while its founder YT Jia added $4 million through an FF Global Partners loan, securing about 7% more.The investment is part of Faraday’s broader plan to rebrand Qualigen as CXC10, shifting focus from biotech to crypto and Web3 under a three-pronged strategy, including the C10 value anchor, BesTrade DeAI Agent, and ecosystem tokens such as a planned stablecoin.Jia said the initiative aims to connect AI and crypto, bridging Web2 and Web3 technologies to create value for both shareholders and token holders.Faraday previously revealed that the C10 Treasury had already deployed $10 million in crypto assets, generating an unrealized 7% gain by mid-September, outperforming the C10 Index benchmark.<h2 class="st-heading-2">Stocktwits Traders Eye Profit-Taking</h2>On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 7,700% surge in 24-hour message volume.<figure class="image"><img style="aspect-ratio:974/145;" src="https://news.stocktwits-cdn.com/qlgn_ss_jpg_a58a8fc680.webp" alt="qlgn ss.jpg" width="974" height="145"><figcaption>QLGN sentiment and message volume as of October 23 | Source: Stocktwits</figcaption></figure>One user said they had bought shares of Qualigen but didn’t expect the rally to last, adding that crypto treasuries seemed to be losing steam and they planned to sell if the stock reached $6.<stembedurl>https://stocktwits.com/FreshlySqueezed23/message/633525946</stembedurl>Another user cautioned traders to “take profit now,” noting that Friday could turn into a “bear day” for Qualigen.<stembedurl>https://stocktwits.com/Faith720/message/633519775</stembedurl><a href="https://stocktwits.com/symbol/QLGN">Qualigen’s stock</a> has declined 16% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Qualigen’s stock (QLGN) has declined 16% so far in 2025. (Photo credit: Getty Images)

Qualigen Therapeutics Stock Soars 62% After-Hours On BitGo Crypto Deal — Traders Warn Of ‘Bear Day’ Ahead

The company plans to diversify holdings across the top 10 cryptocurrencies through BitGo’s custody and OTC trading platform.

Equity

Shares of Qualigen Therapeutics soared as the top gainer among U.S.-listed stocks in pre-market trading on Monday, jumping over&nbsp;285%,&nbsp;driven by news of a major investment amid a strategic pivot.Late Friday, California-based EV maker Faraday Future Intelligent Electric said it will invest $41 million in Qualigen, giving the EV maker a majority stake in the biotech firm as it pivots into crypto and Web3.Faraday will put in $30 million for about 55% of Qualigen's stock, while founder and co-CEO YT Jia will add $4 million through a loan from FF Global Partners, securing about 7% ownership. Jia agreed to lock up his shares for two years. The announcement was made at Faraday's annual "919" event in Los Angeles.Other investors in the round include SIGN Foundation, a blockchain firm backed by Binance Labs, Sequoia Capital, IDG, and Circle. If approved by Qualigen stockholders, the transaction will give Faraday Future a controlling stake, board nomination rights, and leadership roles at the biotech, which plans to rebrand as CXC10.CXC10 will shift focus to a new crypto and Web3 strategy built on three “growth engines”: the C10 value anchor, including a treasury, index, and potential ETF; the BesTrade DeAI Agent to guide trading; and ecosystem tokens, including a planned stablecoin.&nbsp;YT Jia said these efforts would connect AI with crypto and bridge Web2 and Web3, maximizing value for both stockholders and token holders.Faraday Future highlighted C10 Treasury’s early performance, with $10 million in crypto asset allocations delivering an unrealized 7% gain by Sept. 18, beating the C10 Index.The company also used the 919 event to showcase updates to its FX Super One MPV, including a panoramic dual-screen interior, eye-tracking and gesture controls, and generative AI-powered software under its EAI OS. The first U.S. deliveries are scheduled to begin by year-end, with a Middle East launch expected in October.On Stocktwits, retail sentiment for Qualigen Therapeutics was ‘extremely bullish’ with ‘extremely high’ message volume, while for Faraday Future it was ‘neutral’ with ‘normal’ activity.One user described the investment as a “massive” infusion of capital into the company and suggested the development justified a $50 valuation for QLGN.<stembedurl>https://stocktwits.com/madape/message/629471080</stembedurl>Another user said that they expected the stock to trade above $40.<stembedurl>https://stocktwits.com/cardstalktoday/message/629470820</stembedurl>While&nbsp;<a href="https://stocktwits.com/symbol/QLGN">Qualigen’s stock</a> has declined 32.5% so far in 2025,&nbsp;<a href="https://stocktwits.com/symbol/FFAI">Faraday Future’s stock</a> has fallen 27.2% over the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.

While Qualigen’s stock (QLGN) has declined 32.5% so far in 2025, Faraday Future’s stock (FFAI) has fallen 27.2% over the same period. (Photo credit: Getty Images)

Why Is Qualigen Therapeutics’ Stock Surging Nearly 300% Premarket?

The stock surged pre-market after Faraday Future announced a $41 million investment that will give it control as the biotech pivots to a new CXC10 crypto and Web3 strategy.

Qualigen Therapeutics Secures Loan and Expands Equity

Qualigen Therapeutics (QLGN) has provided an announcement. Qualigen Therapeutics, Inc. has struck a financing deal with an institutional investor...

Qualigen Therapeutics (NASDAQ:QLGN) Trading 1.3% Higher

Shares of Qualigen Therapeutics, Inc. (NASDAQ:QLGN - Get Free Report) rose 1.3% on Tuesday . The stock traded as high as $0.45 and last traded at $0.40. Approximately 88,072 shares traded hands...

Qualigen Therapeutics Ends Deal with Pan-RAS Holdings

The latest update is out from Qualigen Therapeutics Inc (QLGN). A Termination Agreement was finalized on March 25, 2024, ending a prior arrangement...

Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company was founded on March 29, 2004 and is headquartered in Carlsbad, CA.

QLGN
Qualigen Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest QLGN News

QLGNQualigen Therapeutics Inc